PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

Market Cap	9.20B
Revenue (ttm)	1.77B
Net Income (ttm)	205.85M
Shares Out	198.89M
EPS (ttm)	1.03
PE Ratio	44.90
Forward PE	42.44
Dividend	0.28 (0.60%)
Ex-Dividend Date	May 30, 2025

Volume	11,994,862
Average Volume	17,835,765
Open	48.37
Previous Close	46.26
Day's Range	44.20 - 48.37
52-Week Range	24.38 - 53.54
Beta	0.72
RSI	59.08
Earnings Date	Aug 8, 2025

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and Full Time Equivalent (FTE). The company also provides small molecule drug substance CDMO se...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 2,455
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300725

Financial Performance

In 2024, SHE:300725's revenue was 1.69 billion, a decrease of -2.12% compared to the previous year's 1.73 billion. Earnings were 219.54 million, an increase of 11.24%.